Pacific Center for Financial Services’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20
Closed 350
2020
Q4
$0 Hold
20
﹤0.01% 350
2020
Q3
$0 Hold
20
﹤0.01% 324
2020
Q2
$0 Hold
20
﹤0.01% 322
2020
Q1
$0 Hold
20
﹤0.01% 320
2019
Q4
$0 Hold
20
﹤0.01% 335
2019
Q3
$0 Hold
20
﹤0.01% 344
2019
Q2
$0 Hold
20
﹤0.01% 336
2019
Q1
$1K Hold
20
﹤0.01% 308
2018
Q4
$1K Hold
20
﹤0.01% 318
2018
Q3
$1K Hold
20
﹤0.01% 310
2018
Q2
$1K Hold
20
﹤0.01% 298
2018
Q1
$1K Hold
20
﹤0.01% 295
2017
Q4
$2K Hold
20
﹤0.01% 270
2017
Q3
$2K Buy
+20
New +$2.1K ﹤0.01% 277

Other funds holding BLCM

Pacific Center for Financial Services's BLCM Position: Q1 2021 in Review

Pacific Center for Financial Services sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2021, closing a stake of 20 shares.

Pacific Center for Financial Services first reported a position in BLCM in Q3 2017 and held it in 14 quarters. The position peaked at $2K in Q4 2017. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2021.

  • Pacific Center for Financial Services reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Pacific Center for Financial Services sold 20 Bellicum Pharmaceuticals, Inc. shares in Q1 2021.
  • Pacific Center for Financial Services first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2017 and held it in 14 quarters.
  • Pacific Center for Financial Services's Bellicum Pharmaceuticals, Inc. position peaked at $2K in Q4 2017.
  • 29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2021.

Based on Pacific Center for Financial Services's 13F filing for Q1 2021, filed 17 May 2021.